Lung Cancer- Mitigate Radiation Pneumonitis, Sensitize Tumor

Share Button

The results indicate that Lipo-cur can effectively mitigate Radiation Pneumonitis, reduce fibrosis, and sensitize lung cancer cells to irradiation

Adaptive radiotherapy reduces pneumonitis while controlling lung cancer

Lung cancer is an aggressive forms of cancer. Conventional oncology is limited when it comes to average overall survival rates.  Therefore LC patients must use every evidence-based therapy tool possible to manage their cancer.

As the studies linked and excerpted below explain, pneumonitis can be a challenge for lung cancer patients undergoing radiation therapy.

I’ve worked with two lung cancer patients who underwent extensive radiation therapy for their inoperable lung cancer. Both developed extensive pneumonitis.

Consider evidence-based integrative therapy to both reduce the risk of pneumonitis and/or sensitize lung cancer cells to radiation therapy enhancing the efficacy of this therapy.

I am a long-term survivor of an equally but different cancer. I have managed my “incurable” cancer since 1994 by learning about and employing a spectrum of evidence-based therapies including curcumin.

Have you been diagnosed with lung cancer? If so, what stage? Are you considering undergoing radiation therapy? To learn more about evidence-based, non-conventional lung cancer therapies scroll down the page, post a comment or question and I will reply to you ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer


Pneumonitis or pulmonitis is an inflammation of lung tissue.[1][2] Many factors can cause pneumonitis, including breathing in animal dander, aspiration (inhaling small food particles or vomit “down the wrong pipe”), and receiving radiation therapy to the chest.[3]..”

Adaptive radiotherapy reduces pneumonitis while controlling lung cancer

“Lung cancer patients who are treated with radiotherapy can develop an inflammation of the lung tissue called pneumonitis; this can limit the dose of radiation they can receive and severe forms of pneumonitis, if left untreated, can be fatal…

A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation

“Radiation pneumonitis (RP) is an important dose-limiting toxicity during thoracic radiotherapy. Previous investigations have shown that curcumin is used for the treatment of inflammatory conditions and cancer, suggesting that curcumin may prevent RP and sensitize cancer cells to irradiation. However, the clinical advancement of curcumin is limited by its poor water solubility and low bioavailability after oral administration…

Conclusion- In this study, a water-soluble Lipo-cur system was successfully developed. The results indicate that Lipo-cur can effectively mitigate RP, reduce the fibrosis of lung, and sensitize LL/2 cells to irradiation. This study also suggests that the systemic administration of Lipo-cur is safe and deserves to be investigated for further clinical application.”


Leave a Comment:

1 comment
Add Your Reply